|
BTG3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.656800E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.538530E-03 |
| Normal-vs-Stage2 |
9.961800E-02 |
| Normal-vs-Stage3 |
1.131630E-02 |
| Normal-vs-Stage4 |
5.180000E-04 |
| Stage1-vs-Stage2 |
2.09539999999064E-05 |
| Stage1-vs-Stage3 |
7.846200E-01 |
| Stage1-vs-Stage4 |
2.934400E-01 |
| Stage2-vs-Stage3 |
1.594110E-04 |
| Stage2-vs-Stage4 |
1.0732999999874E-06 |
| Stage3-vs-Stage4 |
2.375800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.840300E-03 |
| Normal-vs-AfricanAmerican |
1.120410E-03 |
| Normal-vs-Asian |
1.380170E-02 |
| Caucasian-vs-AfricanAmerican |
1.491600E-01 |
| Caucasian-vs-Asian |
8.113200E-01 |
| AfricanAmerican-vs-Asian |
2.895400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.156400E-02 |
| Normal-vs-Female |
8.938900E-03 |
| Male-vs-Female |
9.571000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.813710E-04 |
| Normal-vs-Age(41-60Yrs) |
3.000200E-02 |
| Normal-vs-Age(61-80Yrs) |
8.179400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.603000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.922300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.424800E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.691800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.176400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.520200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.037790E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.213500E-02 |
| Classical-VS-Follicular |
3.10862446895044E-15 |
| Classical-VS-Other |
4.571200E-01 |
| Classical-VS-Normal |
6.0665999999987E-05 |
| Tall-VS-Follicular |
2.206600013821E-09 |
| Tall-VS-Other |
1.079640E-01 |
| Tall-VS-Normal |
3.38669999999652E-06 |
| Follicular-VS-Other |
7.954300E-02 |
| Follicular-VS-Normal |
2.958000E-02 |
| Other-VS-Normal |
3.487200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.698600E-01 |
| Normal-vs-N1 |
4.370400E-04 |
| N0-vs-N1 |
9.86539999999758E-05 |
|
|
